Artículos por temáticas
En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.
Tema
Corea y enfermedad de Huntington
440 ARTíCULOS , VIENDO DEL 46 AL 60
Suicidal ideation in a European Huntington's disease population.
Hubers AA, van Duijn E, Roos RA, Craufurd D, Rickards H, Bernhard Landwehrmeyer G, van der Mast RC, Giltay EJ; REGISTRY investigators of the European Huntington's Disease Network..
J Affect Disord. 2013 Oct;151(1):248-58. doi: 10.1016/j.jad.2013.06.001.
0
0
0
Hawkins AK, Creighton S, Ho A, McManus B, Hayden MR.
Clin Genet. 2013 Jul;84(1):60-4. doi: 10.1111/cge.12033.
0
0
0
Diffusion-weighted imaging in Sydenham's chorea.
Gumus H, Gumus G, Per H, Yikilmaz A, Canpolat M, Poyrazoglu G, Narin N.
Childs Nerv Syst. 2013 Jan;29(1):125-30. doi: 10.1007/s00381-012-1898-2.
0
0
0
Physical therapy in Huntington's disease--toward objective assessments?
Bohlen S, Ekwall C, Hellström K, Vesterlin H, Björnefur M, Wiklund L, Reilmann R.
Eur J Neurol. 2013 Feb;20(2):389-93. doi: 10.1111/j.1468-1331.2012.03760.x.
0
0
0
Huntington's disease: underlying molecular mechanisms and emerging concepts.
Labbadia J, Morimoto RI.
Trends Biochem Sci. 2013 Aug;38(8):378-85. doi: 10.1016/j.tibs.2013.05.003. Review.
0
0
0
[The marginal with Huntington's disease].
Berg T.
Tidsskr Nor Laegeforen. 2013 Oct 29;133(20):2167. doi: 10.4045/tidsskr.13.0878. Norwegian. No abstract available.
0
0
0
Altered Fractional Anisotropy in Early Huntington's Disease.
Singh S, Mehta H, Fekete R.
Case Rep Neurol. 2013 Jan;5(1):26-30. doi: 10.1159/000348399.
0
0
0
Metzger S, Walter C, Riess O, Roos RA, Nielsen JE, Craufurd D; REGISTRY Investigators of the European Huntington’s Disease Network., Nguyen HP.
PLoS One. 2013 Jul 22;8(7):e68951. doi: 10.1371/journal.pone.0068951.
0
0
0
Chorea and retinal vessel occlusion in a patient with systemic lupus erythematosus.
Ostovan VR, Ghorbani A.
Iran J Neurol. 2013;12(2):66-8.
0
0
0
Genome-wide increase in histone H2A ubiquitylation in a mouse model of Huntington's disease.
McFarland KN, Das S, Sun TT, Leyfer D, Kim MO, Xia E, Sangrey GR, Kuhn A, Luthi-Carter R, Clark TW, Sadri-Vakili G, Cha JH.
J Huntingtons Dis. 2013;2(3):263-77. doi: 10.3233/JHD-130066.
0
0
0
Huntington's disease gene expansion associates with early onset nonprogressive chorea.
Dosa L, Malandrini A, Di Donato I, Hladnik U, Meloni I, Mari F, Federico A.
Mov Disord. 2013 May;28(5):684. doi: 10.1002/mds.25443. No abstract available.
0
0
0
Late onset vascular dysfunction in the R6/1 model of Huntington's disease.
Rahman A, Ekman M, Shakirova Y, Andersson KE, Mörgelin M, Erjefält JS, Brundin P, Li JY, Swärd K.
Eur J Pharmacol. 2013 Jan 5;698(1-3):345-53. doi: 10.1016/j.ejphar.2012.10.026.
0
0
0
McLeod MC, Kobayashi NR, Sen A, Baghbaderani BA, Sadi D, Ulalia R, Behie LA, Mendez I.
Cell Transplant. 2013;22(12):2237-56. doi: 10.3727/096368912X658809.
0
0
0
Golgi protein ACBD3 mediates neurotoxicity associated with Huntington's disease.
Sbodio JI, Paul BD, Machamer CE, Snyder SH.
Cell Rep. 2013 Sep 12;4(5):890-7. doi: 10.1016/j.celrep.2013.08.001.
0
0
0
Sarkar S.
Drug Discov Today Technol. 2013 Spring;10(1):e137-44. doi: 10.1016/j.ddtec.2012.09.010. Review.
0
0
0
Comentarios
En ningún caso la información facilitada constituye asesoramiento por parte de Zambon
Con el aval de:
En colaboración con:
